Brief: Belite Bio Announces Pricing Of $30 mln Underwritten Public Offering Of ADS And Warrants
31/05/2023 01:52
May 30 (Reuters) - Belite Bio Inc BLTE.O :
* ANNOUNCES PRICING OF $30 MILLION UNDERWRITTEN PUBLIC
OFFERING OF
AMERICAN DEPOSITARY SHARES AND WARRANTS
* PRICED AN UNDERWRITTEN PUBLIC OFFERING OF 2 MILLION ADS AT
A
PRICE OF $15.00 PER ADS AND ACCOMPANYING WARRANT
Source: urn:newsml:reuters.com:*:nGNX1rmrQt
Further company coverage: BLTE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Belite Bio
See all newsBrief: Belite Bio Announces Uplisting To The Nasdaq Global Select Market
Brief: Belite Bio Announces Multi-Market Submission Of Marketing Authorization Applications Via The Access Consortium Pathway For Tinlarebant For The Treatment Of Stargardt Disease Type 1
Brief: Belite Bio Announces Submission Of New Drug Application To The Ministry Of Health, Labour, And Welfare In Japan Under The Sakigake Designation System For Tinlarebant For The Treatment Of Stargardt Disease Type 1
Belite Bio, Inc reports results for the quarter ended June 30 - Earnings Summary
Belite Bio Q2 net loss widens on higher expenses